Current Drug Targets
Title:Editorial (Thematic Issue: Glia: A New Cellular Target in the Treatment of Major Depression)
Volume: 14 Issue: 11
Author(s): Bruno Guiard
Affiliation:
Export Options
About this article
Cite this article as:
Guiard Bruno, Editorial (Thematic Issue: Glia: A New Cellular Target in the Treatment of Major Depression), Current Drug Targets 2013; 14 (11) . https://dx.doi.org/10.2174/13894501113149990207
DOI https://dx.doi.org/10.2174/13894501113149990207 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanoparticulate Drug Delivery System to Overcome the Limitations of Conventional Curcumin in the Treatment of Various Cancers: A Review
Drug Delivery Letters Counter-Transference and Neutrality: A Challenge for Abortion Counsellor
Current Women`s Health Reviews Roles of a Novel Molecule ‘Shati’ in the Development of Methamphetamine-Induced Dependence
Current Neuropharmacology Protein Aggregation in Neurodegenerative Diseases: Insights from Computational Analyses
Current Bioinformatics Pitx2 Expression Promotes p21 Expression and Cell Cycle Exit in Neural Stem Cells
CNS & Neurological Disorders - Drug Targets A Comparison of Emotional Decoding Abilities in Patients with Amnestic Mild Cognitive Impairment, Very Mild and Mild Alzheimer’s Disease
Current Alzheimer Research Depression and Medication Adherence in Patients on Hemodialysis
Current Hypertension Reviews Neuroprotection by the α2-Adrenoceptor Agonist, Dexmedetomidine, in Experimental Stroke Models
Vascular Disease Prevention (Discontinued) Suicide and the Polyamine System
CNS & Neurological Disorders - Drug Targets Respiratory Muscle Dysfunction in COPD: From Muscle to Cell
Current Drug Targets Synthesis of Oligopeptides Through O-acyl Isopeptide Method
Protein & Peptide Letters Supplementation of Creatine and Ribose Prevents Apoptosis and Right Ventricle Hypertrophy in Hypoxic Hearts
Current Pharmaceutical Design Strategies of Engineering Nanoparticles for Treating Neurodegenerative Disorders
Current Drug Metabolism Antisense Oligonucleotides as an Innovative Therapeutic Strategy in the Treatment of High-Grade Gliomas
Recent Patents on CNS Drug Discovery (Discontinued) Mitochondrial Abnormalities in a Streptozotocin-Induced Rat Model of Sporadic Alzheimer's Disease
Current Alzheimer Research Current Status and Future Prospects of Small–molecule Protein–protein Interaction (PPI) Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
Current Topics in Medicinal Chemistry Melanocortin-4 Receptor Antagonists for the Treatment of Depression and Anxiety Disorders
Current Topics in Medicinal Chemistry Chemoprevention with Phytonutrients and Microalgae Products in Chronic Inflammation and Colon Cancer
Current Pharmaceutical Design Platinum-Intercalator Conjugates: From DNA-Targeted Cisplatin Derivatives to Adenine Binding Complexes as Potential Modulators of Gene Regulation
Current Topics in Medicinal Chemistry IAPs as a Target for Anticancer Therapy
Current Cancer Drug Targets